Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2024 > Vol 5, №10 (2024) > Similarity of the gastrointestinal mechanisms underlying the development of osteoporosis and diabetes mellitus

Similarity of the gastrointestinal mechanisms underlying the development of osteoporosis and diabetes mellitus

Elena V. Doskina

For citation:


  • Abstract
  • About the Author
  • References

Abstract

There is an annual increase in patients with diabetes mellitus (DM). Consequently, the number of patients with complications of diabetes mellitus is also increasing – diabetic polyneuropathy, osteoporosis (OP), etc. Diabetes mellitus and osteoporosis have many common pathogenetic links, especially from the gastrointestinal tract and the hepatobiliary system. Timely early initiation of therapeutic and preventive measures helps to prevent the development of complications in the form of fractures in patients with diabetoporosis and OP and DM. The selection of adequate hypoglycemic therapy is impossible without meticulous self-monitoring and assessment of glycemia. The choice of a blood glucose meter is an important part of the therapeutic training and treatment of a patient with diabetes mellitus, both in the initial stages and in the presence of complications.
Keywords: diabetes mellitus, osteoporosis, pathogenesis, hypoglycemia, self-control.

About the Author

Elena V. Doskina 1

1 Russian Medical Academy of Continuous Professional Education, Moscow, Russia

References

1. International Diabetes Federation. URL: https://idf.org/
2. Ali D, Tencerova M, Figeac F. et al. The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity. Front Endocrinol (Lausanne) 2022;13:981487. DOI:
3. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int (2006) 17:1726-33. DOI: 10.1007/s00198-006-0172-4
4. Sanjay Kalra, Ameya Joshi, Nitin Kapoor. Osteoporosis and diabetes: The dual pandemics. J Pak Med Assoc 2022 Aug;72(8):1663-4. DOI: 10.47391/JPMA.22-86
5. Карманный справочник по остеопорозу. Под ред. С.Л. Феррари, К. Ру. Пер. с англ. под ред. проф. О.М. Лесняк. М.: ГЭОТАР, 2020.
Pocket guide to osteoporosis. Edited by N. S.L. Ferrari, K. Ru. Per. see edited by N. Prof. O.M. Lesnyak. Moscow: GEOTAR, 2020 (in Russian).
6. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. М., 2023.
Algorithms of specialized medical care for patients with diabetes mellitus. Edited by I.I. Dedov, M.V. Shestakova, A.Yu. Mayorov. Moscow, 2023 (in Russian).
7. Borst SE. The Role of TNF-α in Insulin Resistance. Endocrine 2004;23(2-3):177-82. DOI: 10.1385/ENDO:23:2-3:177
8. Yang YM, Seki E. TNFα in Liver Fibrosis. Curr Pathobiol Rep 2015;3(4):253-61. DOI: 10.1007/s40139-015-0093-z
9. Coffin CS, Fraser HF, Panaccione R, Ghosh S. Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-α) use for inflammatory bowel disease. Inflamm Bowel Dis 2011;17(1):479-84. DOI: 10.1002/ibd.21336
10. Sawada M, Kiyono T, Nakashima S et al. Molecular mechanisms of TNF-α-induced ceramide formation in human glioma cells: P53-mediated oxidant stress-dependent and independent pathways. Cell Death Differ 2004;11(9):997-1008. DOI: 10.1038/sj.cdd.4401438
11. Ткачук В.А., Воротников А.В. Молекулярные механизмы развития резистентности к инсулину. Сахарный диабет. 2014;17(2):29-40. DOI: 10.14341/DM2014229-40
Tkachuk V.A., Vorotnikov A.V. Molecular mechanisms for the development of insulin resistance. Sakharnyi Diabet. 2014;17(2):29-40. DOI: 10.14341/DM2014229-40 (in Russian).
12. Stefan N, Fritsche A, Weikert C et al. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 2008;57(10):2762-7. DOI: 10.2337/db08-0538
13. Мишина Е.Е., Майоров А.Ю., Богомолов П.О. и др. Неалкогольная жировая болезнь печени: причина или следствие инсулинорезистентности? Сахарный диабет. 2017;20(5):335-43. DOI: 10.14341/DM9372
Mishina E.E., Majorov A.Yu., Bogomolov P.O. et al. Non-alcoholic fatty liver disease: a cause or consequence of insulin resistance? Sakharnyi Diabet 2017;20(5):335-43. DOI: 10.14341/DM9372 (in Russian).
14. Калмыкова З.А., Кононенко И.В., Майоров А.Ю. Сахарный диабет и хронические заболевания печени. Часть 1: общие механизмы этиологии и патогенеза. Терапевтический архив. 2019;10:106-11.
Kalmykova Z.A., Kononenko I.V., Mayorov A.Yu. Diabetes mellitus and chronic liver diseases. Part 1: General mechanisms of etiology and pathogenesis. Therapeutic Archive. 2019;10:106-111. (in Russian).
15. Distribution of Pharmacogenetic Polymorphisms and the Intervention Effects of Folic Acid Combined with Vitamin D in Community-based Patients with H-type Hypertension;27(6):704-10. DOI: 10.12114/j.issn. 1007-9572.2023.0457
16. Naimov Dilshod Qayim o’g’li Peculiarities of the use of prepat in vitamin d deficiency https://www.sciencebox.uz/index.php/sjeg/article/ view/9127
17. Jeffrey D. Roizen, Michael A. Levine – The role of genetic variation in CYP2R1, the principal vitamin D 25-hydroxylase, and CYP3A4 in vitamin D homeostasis Volume Two: Health, Disease and Therapeutics 2024:341-357. https://www.sciencedirect.com/science/article/abs/ pii/B9780323913386000173
18. Slominski AT, Tuckey RC, Jenkinson C et al. Alternative pathways for vitamin D metabolism Volume One: Biochemistry. Physiology and Diagnostics 2024:85-109. https://www.sciencedirect.com/science/article/abs/pii/B9780323913867000015
19. Weber F. Absorption mechanisms for fat-soluble vitamins and the effect of other food constituents. Prog Clin Biol Res 1981;77
:119-135.
20. Yu S, Cantorna MT. Epigenetic reduction in invariant NKT cells following in utero vitamin D deficiency in mice. J Immunol 2011;186(3):1384-90. DOI: 10.4049/jimmunol.1002545
21. Дьяков Д.A., Акбашева О.Е. Оксидативный стресс и система протеолиза при сахарном диабете 2-го типа. Сахарный диабет. 2022;25(1):14-20.
Dyakov D.A., Akbasheva O.E. Oxidative stress and the proteolysis system in type 2 diabetes mellitus. Sakharnyi diabet. 2022;25(1):14-20 (in Russian).
22. Khutami C, Sumiwi SA, Khairul Ikram NK, Muchtaridi M. The Effects of Antioxidants from Natural Products on Obesity, Dyslipidemia, Diabetes and Their Molecular Signaling Mechanism. Int J Mol Sci 2022;23(4):2056. DOI: 10.3390/ijms23042056.
23. Светлова О.В., Гурьева И.В. Новый уровень технологий – новый уровень самоконтроля в управлении сахарным диабетом. Медицинский совет. 2015;7:48-50.
Svetlova O.V., Guryeva I.V. A new level of technology is a new level of self–control in the management of diabetes mellitus. Medical advice. 2015;7:48-50 (in Russian).
24. Национальный стандарт РФ. URL: The national standard of the Russian Federation. URL: https://docs.cntd.ru/document/ 1200120137
25. Остеопороз. Клинические рекомендации. URL: https://cr.minzdrav.gov.ru/schema/87_4
Osteoporosis. Clinical recommendations. URL: https://cr.minzdrav. gov.ru/schema/87_4 (in Russian).
26. Дефицит витамина D. Клинические рекомендации. URL: Vitamin D deficiency. Clinical recommendations. URL: https://www.endocrincentr.ru/sites/default/files/specialists/science/clinic-recomendations/kr_deficit_vitamina_d_2021.pdf (in Russian).
27. Методическое руководство Организация работы кабинета «Школа для пациентов с сахарным диабетом» Разработчик методического руководства: Общественная организация «Российская ассоциация эндокринологов» 2022 г. URL: https://edu.endocrincentr.ru/stes/ default/files/all/files/pdf/%D0%9C%D0%B5%D1%82%D0%BE%D0%B4%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%BE%D0%B5%20%D1%80%D1%83%D0%BA%D0%BE%D0%B2%D0%BE%D0%B4%D1%81%D1%82%D0%B2%D0%BE%20%D0%BF%D0%BE%20%D1%88%D0%BA%D0%BE%D0%BB%D0%B0%D0%BC%20%D0%B4%D0%B8%D0%B0%D0%B1%D0%B5%D1%82%D0%B0_%D1%81%20%D0%BF%D0%BE%D1%80%D1%8F%D0%B4%D0%BA%D0%BE%D0%BC%202012%20%D0%B3%D0%BE%D0%B4%D0%B0_01.08.2022%20%283%29.pdf
Methodological guidance Organization of the office «School for patients with diabetes mellitus» Developer of the methodological guidance: Public organization «Russian Association of Endocrinologists» 2022 . URL: https://edu.endocrincentr.ru/sites/default/files/all/files/pdf/%D0%9C%D0%B5%D1%82%D0%

Портал CON-MED.RU:
https://con-med.ru/magazines/klinicheskiy_razbor_v_obshchey_meditsine/klinicheskiy_razbor_v_obshchey_meditsine-10-2024/obshchnost_patogeneticheskikh_gastroenterologicheskikh_mekhanizmov_razvitiya_osteoporoza_i_sakharnog/
BE%D0%B4%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%BE%D0%B5%20%D1%80%D1%83%D0%BA%D0%BE%D0%B2%D0%BE%D0%B4%D1%81%D1%82%D0%B2%D0%BE%20%D0%BF%D0%BE%20%D1%88%D0%BA%D0%BE%D0%BB%D0%B0%D0%BC%20%D0%B4%D0%B8%D0%B0%D0%B1%D0%B5%D1%82%D0%B0_%D1%81%20%D0%BF%D0%BE%D1%80%D1%8F%D0%B4%D0%BA%D0%BE%D0%BC%202012%20%D0%B3%D0%BE%D0%B4%D0%B0_01.08.2022%20%283%29.pdf

For citation:Doskina E.V. Similarity of the gastrointestinal mechanisms underlying the development of osteoporosis and diabetes mellitus. Clinical review for general practice. 2024; 5 (10): 98–106. (In Russ.). DOI: 10.47407/kr2024.5.10.00502


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru